Dr. Alfredo Samuel Archilla, MD

Dr. Archilla practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Archilla's NPI, 1952329138, was assigned on July 17, 2006. Dr. Archilla graduated from Ponce Health Sciences University School of Medicine in 2006. Dr. Archilla holds Florida license ME112998.

Dr. Archilla's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Archilla's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Archilla is also affiliated with Boca Raton Regional Hospital. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Archilla to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Archilla practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Archilla's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Archilla is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Archilla's licenses on file in 2 states: Florida and Tennessee.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Archilla treats.

CMS data shows 4,285 Medicare services from Dr. Archilla across 20 procedure codes in 2024, for 1,045 Medicare patients. Medicare paid $299,370 for them.

CMS counts 1,045 Medicare patients who saw Dr. Archilla in 2024. The largest group is 75 to 84, with 479 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Archilla's median patient age at 61, with 60% women.

In 2024, Dr. Archilla wrote 1,473 Medicare Part D claims for 522 patients. 98% of them were for generic drugs. CMS names the drug for 1,347 of them, across 18 drugs with 11 or more claims each, at $22,673 in total drug cost. In 2023, CMS named 1,347 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Archilla for performance year 2024, reported individually. Dr. Archilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Archilla as offering telehealth.

Dmand AI links 6 papers to Dr. Archilla, published from 2010 to 2025. The most frequent topics are Endoscopy and Sinusitis. Dr. Archilla has published most often in Ear Nose Throat J. Dr. Archilla's most frequent co-authors are Gennadiy Vengerovich, David Jeffrey Kay, MD, MPH and Nima Khosravani, MD.

CMS Open Payments shows 147 general payments to Dr. Archilla from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Optinose US, Inc. paid the most, $16,872.

Dr. Archilla graduated from Ponce Health Sciences University School of Medicine in 2006.

Dr. Archilla is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.